Overview

A Study to Compare PK, PD and Safety of the AD-206 and Esomeprazole

Status:
Completed
Trial end date:
2020-06-18
Target enrollment:
Participant gender:
Summary
A study to compare safety, pharmacokinetics and pharmacodynamics of AD-206 to Esomeprazole in healthy male volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Addpharma Inc.
Treatments:
Esomeprazole